Overview of Therapeutic Drug Monitoring MarketThe Global Therapeutic Drug Monitoring Market is valued at USD 2.5 Billion in ...

A common asthma inhaler has been recalled in the UK due to a labelling error that could mislead patients about their dosage.

Astegolimab, an anti-ST2 monoclonal antibody designed to block signaling of IL-33 under development by Roche's (OTCQX:RHHBY) Genentech unit, failed to meet its primary endpoint in a phase 3 trial for ...

Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an ...

Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...

Asthma is an illness that commonly affects adults and children, and it serves as a common reason for children to attend emergency departments. An asthma exacerbation is characterised by acute or ...

Jeremy Derozin is the fifth trainer from AQHA's Top 10 earnings list in 2024 to be sidelined for a positive test of the non-FDA approved bronchodilator ...

Inhaled steroids aren’t the go-to treatment for COPD, so your doctor will likely prescribe a bronchodilator, too. This is medicine in an inhaler that relaxes your airway muscles to help you ...

Find out the most effective COPD treatment plan that combines medications, lifestyle changes, and breathing exercises to reduce flare-ups and hospital visits.

The new recommendations specifically warn against anyone with asthma using a short-acting bronchodilator such as salbutamol by itself, due to the increased health risks mentioned above.